ptaxg74 | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Titanji%2C_Boghuma_K%3B_Farley%2C_Monica_M%3B_Schinazi%2C_Raymond_F%3B_Marconi%2C_Vincent_C>
?:doi	10.1093/cid/ciaa1210
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/cid/ciaa1210>
?:journal	Clin_Infect_Dis
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/b357c6f6a1c161181af284812c4bbbd5543e69c6.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7454400>
?:pmid	<https://research.tib.eu/covid-19/entity/32797226.0>
?:pmid	32797226.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/b357c6f6a1c161181af284812c4bbbd5543e69c6>
?:source	Medline; PMC
?:title	Response to Correspondence: Baricitinib – Impact on COVID-19 Coagulopathy? Jorgensen et. al.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-08-14

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/6ptaxg74>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/6ptaxg74>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all